Correction

With regard to the article in the October 2016 issue entitled "Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests" (J Allergy Clin Immunol 2016;138:943-55), it has been brought to the Editors' attention that an incorrect gene was used in the upper paragraphs in the second column on page 951. The term HLA-B*1502 is used instead of HLA-B*5801. The authors regret the error.

http://ift.tt/2iTq1Qr